custom image

COVID-19: One Year Later

February 8-9, 2021 | 3:00PM EST | 8:00PM UTC*
*Program is in development and subject to change

Advanced Filters

We aspire to be the premier research-intensive biopharmaceutical company in the world

For more than 125 years, Merck (known as MSD outside of the U.S. and Canada) has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives.

We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.

Today, we continue to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases, such as HIV and Ebola, and emerging animal diseases.

Sust. Benefactor

AstraZeneca R&D High Level Overview:

We are driven by science, united by science, and every day, we push the boundaries of science to deliver life-changing medicines.

Link for more information:

Microbial Sciences:

Our business model thrives on being dynamic and partly externalized, with a firm focus on driving science in our key areas of interest. Early, flexible partnering with the brightest and best in the world allows us to combine knowledge and progress clinical development, while managing the challenges associated with neuroscience and microbial science research.

Link for more information:


We are committed to defining new standards of care for patients with cardiovascular disease, heart failure, metabolic diseases, such as diabetes and non-alcoholic steatohepatitis (NASH), and chronic kidney disease (CKD) - improving their outcomes and decreasing mortality rates.

Link for more information:

Respiratory / Immunology:

We are aiming to transform the treatment of respiratory diseases, with our growing portfolio of inhaled combinations at the core of care, biologics for the unmet needs of specific patient populations, and scientific advancements in disease modification.

Link for more information:

Sust. Sponsor

Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer and auto-immune disease. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates.

Our success is rooted in four key elements:

  • Our track record reflected by a portfolio of successful approved medicines which emanated from our chemistry platform and are made available globally by our pharmaceutical partners
  • Our unique research and development pipeline of new investigational medicines in cancer and immunology
  • Our proprietary and proven science and technology approach that fuels our discovery efforts
  • Our team of dedicated scientists, clinicians and employees focused on bringing new medicines to patients with debilitating diseases
Sust. Sponsor

Mission & Core Values

At Gilead, we’re committed to creating possible. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases.

Through bold and transformative science, we’re creating possibilities that have the potential to become the next generation of life-changing medicines. Our ambition is evident in our mission. Because the impossible is not impossible. It’s what’s next.


To create a better, healthier world for all people.


To discover, develop and deliver innovative therapeutics for people with life-threatening diseases.

Core Values

Integrity: Doing What’s Right, Inclusion: Encouraging Diversity, Teamwork: Working Together, Accountability: Taking Personal Responsibility, Excellence: Being Your Best


People. Passion. Possibilities.®

We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company.


AdipoGen Life Sciences is an original manufacturer and distributor of life science research reagents, well positioned in key research areas like immuno-oncology, immunometabolism, adaptive and innate immunity (expert in inflammasome), metabolic syndrome (diabetes, obesity) and cell trafficking, to support Advanced Inflammation, Immune Response & Immunometabolic Research. A motivated team of highly skilled individuals develops and manufactures advanced ELISA kits, proteins, antibodies and new and innovative small molecules. For details